The DOI matches its Crossref record.
Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy
Open accessAbstract
BACKGROUND: The acute coagulopathy of trauma is present in up to one third of patients by the time of admission, and the recent CRASH-2 and MATTERs trials have focused worldwide attention on hyperfibrinolysis as a component of acute coagulopathy of trauma. Thromboelastography (TEG) is a powerful tool for analyzing fibrinolyis, but a clinically relevant threshold for defining hyperfibrinolysis has yet to be determined. Recent data suggest that the accepted normal upper bound of 7.5% for 30-minute fibrinolysis (LY30) by TEG is inappropriate in severe trauma, as the risk of death rises at much lower levels of clot lysis. We wished to determine the validity of this hypothesis and establish a threshold value to treat fibrinolysis, based on prediction of massive transfusion requirement and risk of mortality. METHODS: Patients with uncontrolled hemorrhage, meeting the massive transfusion protocol (MTP) criteria at admission (n = 73), represent the most severely injured trauma population at our center (median Injury Severity Score [ISS], 30; interquartile range, 20-38). Citrated kaolin TEG was performed at admission blood samples from this population, stratified by LY30, and evaluated for transfusion requirement and 28-day mortality. The same analysis was conducted on available field blood samples from all non-MTP trauma patients (n = 216) in the same period. These represent the general trauma population. RESULTS: Within the MTP-activating population, the cohort of patients with LY30 of 3% or greater was shown to be at much higher risk for requiring a massive transfusion (90.9% vs. 30.5%, p = 0.0008) and dying of hemorrhage (45.5% vs. 4.8%, p = 0.0014) than those with LY30 less than 3%. Similar trends were seen in the general trauma population. CONCLUSION: LY30 of 3% or greater defines clinically relevant hyperfibrinolysis and strongly predicts the requirement for massive transfusion and an increased risk of mortality in trauma patients presenting with uncontrolled hemorrhage. This threshold value for LY30 represents a critical indication for the treatment of fibrinolysis. LEVEL OF EVIDENCE: Prognostic study, level III.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gonzalez, E., Moore, E. E., Moore, H. B., Chapman, M. P., Chin, T. L., Ghasabyan, A., Wohlauer, M. V., Barnett, C. C., Bensard, D. D., Biffl, W. L., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001608 · Cited by 641
Self-citationMoore, H. B., Moore, E. E., Gonzalez, E., Chapman, M. P., Chin, T. L., Silliman, C. C., Banerjee, A., & Sauaia, A. (2014) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000000341 · Cited by 452
Self-citationDa Luz, L. T., Nascimento, B., Shankarakutty, A. K., Rizoli, S., & Adhikari, N. K. (2014) · Critical Care · doi:10.1186/s13054-014-0518-9 · Cited by 308
Moore, H. B., Moore, E. E., Liras, I. N., Gonzalez, E., Harvin, J. A., Holcomb, J. B., Sauaia, A., & Cotton, B. A. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.01.006 · Cited by 295
Self-citationThe role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management
Görlinger, K., Pérez-Ferrer, A., Dirkmann, D., Saner, F., Maegele, M., Calatayud, Á. A. P., & Kim, T.-Y. (2019) · Korean Journal of Anesthesiology · doi:10.4097/kja.19169 · Cited by 257
Metadata
- Authors
- Chapman, M. P., Moore, E. E., Ramos, C. R., Ghasabyan, A., Harr, J. N., Chin, T. L., Stringham, J. R., Sauaia, A., Silliman, C. C., & Banerjee, A.
- Venue
- Journal of Trauma and Acute Care Surgery
- Published
- 2013-12
- Volume
- 75
- Issue
- 6
- Pages
- 961-967
- ISSN
- 2163-0755 (ISSN-L)
- OpenAlex
- W2083139851
- Cited by
- 198
- References
- 0
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. https://app.cochat.ai/papers/10.1097/ta.0b013e3182aa9c9f
- The paper
- Chapman, M. P., Moore, E. E., Ramos, C. R., Ghasabyan, A., Harr, J. N., Chin, T. L., Stringham, J. R., Sauaia, A., Silliman, C. C., & Banerjee, A. (2013). Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. Journal of Trauma and Acute Care Surgery. https://doi.org/10.1097/ta.0b013e3182aa9c9f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.